Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy.
J Immunol
; 201(7): 2094-2106, 2018 10 01.
Article
in En
| MEDLINE
| ID: mdl-30104245
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Recombinant Fusion Proteins
/
Receptors, Interleukin-2
/
Cytokines
/
T-Lymphocytes, Regulatory
/
Colitis
/
Immunotherapy
/
Antibodies
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunol
Year:
2018
Type:
Article